BURLINGTON, Massachusetts, December 12 /PRNewswire/ --

InterGen announced today the financial close and funding of credit facilities for its 428 MW natural gas-fired Rijnmond II project in Rotterdam. With an estimated cost of approximately euro 480 million (US$700 million), the Rijnmond II project will complement InterGen's existing 820 MW Rijnmond Energie project which commenced operations in 2004.

InterGen has appointed HSBC Bank plc as Mandated Lead Arranger and Sole Underwriter for the approximately euro 400 million (US$590 million) non-recourse financing that consists of a euro 335 million (US$490 million) long-term senior debt facility as well as working capital, swap and LC facilities.

LONDON, December 12 /PRNewswire/ -- Following the DH announcement to pilot the availability of oral contraception through Patient Group Directions (PGD), David Pruce, Director of Practice and Quality Improvement at the Royal Pharmaceutical Society of Great Britain, said:

"The Society supports the Department of Health proposal to pilot supply of the contraceptive pill through PGD, which are written instructions for the supply or administration of medicines to groups of patients without an individualised doctor's prescription."

BAAR, Switzerland, December 12 /PRNewswire/ -- DWM Petroleum AG (100% subsidiary of Manas) (DWM) & Santos International Ventures Pty Ltd. (Santos) have entered into an Option Agreement under which Santos has a unilateral option to elect for the those parties to execute at a later stage, a Farm In Agreement for a 70% interest in DWM's Novobod Tajikistan License and a proposed North Tajik licence. Manas expects the North Tajik Licence to be granted to Somon in the near future.

AMSTERDAM, Netherlands, December 12 /PRNewswire/ --

Agendia makes its breast cancer prognosis test, MammaPrint(R), available to U.S. patients after receiving two clearances from the Food and Drug Administration (FDA) for its test. The first clearance in February of this year cleared MammaPrint(R) as an In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for use in breast cancer prognosis. In June of this year, Agendia received a second clearance for the test in conjunction with RNARetain(R)(i), an RNA stabilizing solution allowing shipping of tumor biopsies at ambient temperature, greatly facilitating the logistical process of sample handling.

AUSTIN, Texas, December 12 /PRNewswire/ --

- Supported by REAL SQL Server - 600,000 requests daily with no downtime

REAL Software, a leading producer of cross-platform development software for Windows, Macintosh OS/X and Linux, has launched an expanded global web presence to reflect its international reach. The site is now available in Chinese (Simplified and Traditional), English, French, German, Italian, Japanese and for the first time, Spanish. The dynamic functions of the site are supported by REAL Software's REAL SQL Server, which has handled up to 600,000 requests a day (20 million requests per month) with zero downtime.

AUSTIN, Texas, December 12 /PRNewswire/ --

- DocuSender(TM) Enables a Scanner to E-Mail and Fax Without Using a PC

Ringdale, Inc., a technology leader in network enhancing connectivity solutions, today announced the availability of the ModuLAN(R) DocuSender(TM) - a document scan to e-mail or fax appliance. This unique device works with popular USB-based scanners to provide scan to e-mail or scan to fax functionality, without the need for a PC.

The compact DocuSender connects directly to an Ethernet network, a phone line using Ringdale's PCMCIA modem technology and a compatible scanner. The user scans the document to an e-mail address or fax number using DocuSender's touch panel keypad with digital display.